'Pro-Science' Mom Enrolls Kids In Pfizer CV Vax Trial, 12-Yr-Old Daughter Suffers 'Severe' ReactionsChris Menahan
Jun. 30, 2021
Californians Flee to Montana in Droves, Seek to Turn It Into California
American Jewish Congress Demands Twitter 'Permanently Ban' Rep. Marjorie Taylor Greene
Con Inc Declares Total War On Ben And Jerry's For 'Not Loving Israel Enough'
Czech Republic Enshrines Its Own Second Amendment Into Law
Biden Regime Promotes 'Racial Justice' Guide Pushing Students And Teachers to 'Disrupt Whiteness'
A "pro-vaccine and pro-science" mom who signed her kids up for Pfizer's experimental mRNA covid vaccine trial in December told Senator Ron Johnson at a public hearing on Monday that her 12-year-old daughter suffered "severe" reactions to the shot and had to be hospitalized for months.
"On January 20th, Maddie received her second dose of the Pfizer COVID vaccine as a participant in the clinical trial for 12 -and -15-year-olds," Cincinnati mom Stephanie de Garay said. "All three of our kids volunteered and were excited to participate in the trial as a way to help us all return to normal life. My husband works in the medical field and I have a degree in electrical engineering. We are pro-vaccine and pro-science -- which is why we agreed to let Maddie and her two older brothers volunteer for the trial."
"She had painful electrical shocks down her neck and spine that forced her to walk hunched over," she said. "She had extreme pain in her fingers and toes, and it actually made them turn white, and they were cold whenever you touched them."
"For the past five months, Maddie has been to the ER nine times, has been hospitalized three times, for a total of two months in the hospital," de Garay said. "She was totally fine before this, she did the right thing trying to help everybody else and they're not helping her."
After de Garay's story went viral, Twitter responded by censoring her:
Here's the full conference:
Maddie's story is not unique.
Trust the science!
Follow InformationLiberation on Twitter, Facebook, Gab, Minds, Parler and Telegram.